Advertisement

Topics

Companies Related to "Ibionext Chronolife Appoints Franck Meur Chief Executive Officer" [Most Relevant Company Matches] RSS

00:52 EDT 19th September 2018 | BioPortfolio

Here are the most relevant search results for "Ibionext Chronolife Appoints Franck Meur Chief Executive Officer" found in our extensive corporate database of over 50,000 company records.

Showing "Ibionext Chronolife Appoints Franck Meur Chief Executive Officer" Companies 1–25 of 586

Extremely Relevant

Vantage Oncology, LLC

Founded in October 2002, Manhattan Beach, California-based Vantage Oncology, LLC owns, operates and manages radiation oncology centers of excellence. The company’s founding principles were to address the growing need among cancer patients, hospitals and physicians for easily accessible and advanced radiation treatment therapies. Vantage Oncology curre...


Vantage Oncology

Founded in October 2002, Vantage Oncology acquires, joint ventures, develops and operates radiation oncology centers of excellence. The Company was created in response to the growing need among cancer patients, hospitals and physicians for accessible and advanced radiation treatment therapies. Recent developments at Vantage include the establishment of multi-specialty oncology care organizations ...

Sucampo Pharmaceuticals, Inc. and Numab AG

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company based in Bethesda, Maryland, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids wa...


Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc.

Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids, was first identified ...

Sucampo Pharmaceuticals, Inc. and Takeda

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids, was first identified by Ryuj...

AmeriLithium Corp.

Matthew Worrall, Chief Executive Officer

Vmersion-Health

Vmersion-Health, developer of Gluco-Share, is a California Limited Partnership founded in 2011. Vmersion-Health develops and publishes social media applications for health-related causes, with a commitment to improved health through better communication and social support mechanisms. Joseph “Joe” Madden is president and Chief Executive Officer; J...

Sucampo Pharmaceuticals, Inc. and Abbott

Sucampo Pharmaceuticals, Inc., an international biopharmaceutical company based in Bethesda, Maryland, focuses on the development and commercialization of medicines based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymic (15-PGDH) transformation of certain fatty acids, was first identified ...

Origo Acquisition Corporation

Origo Acquisition Corporation is a public investment vehicle formed for the purpose of effecting a merger, acquisition or similar business combination. Origo is led by Chief Executive Officer Edward J. Fred, Chief Financial Officer Jose M. Aldeanueva and Directors Stephen B. Pudles, Jeffrey J. Gutovich and Barry Rodgers. Origo’s securities are quoted ...

Interface Biologics

Toronto, Canada – August 26, 2005 - Interface Biologics Inc. announced today the appointment of Richard W. Sullivan to the position of President and Chief Executive Officer of the Company.Mr. Sullivan brings more than 30 years of senior management and executive experience in the life sciences industry, having held key positions in early stage corporations since 1990. Most recently, as Chief Exec...

MedDay

MedDay is a privately held biotechnology company developing new drugs for nervous system disorders. The company was founded in 2011 by Frédéric Sedel, MD, PhD (Chief Executive Officer), a leading neurologist and neuroscientist; and Guillaume Brion, MD (Chief Operating Officer) who has 25 years of experience in drug development and clinical research i...

REVOLUTION Medicines

The REVOLUTION Medicines team brings deep expertise and a track record of building exceptional life sciences companies. In addition to Dr. Goldsmith, founding president and chief executive officer and Dr. Burke, founder and scientific advisory board chairman, the team includes: David Pompliano, Ph.D., founding chief scientific officer, who is a leading ...

Harbinger Capital Partners

Harbinger Capital Partners is a multi-billion dollar private investment fund based in New York which employs a fundamental, intensive research-based approach to investing. Harbinger Capital Partners is led by Phil Falcone who has been the Chief Executive Officer and Chief Investment Officer of funds affiliated with or managed by Harbinger Capital Partners ...

IntraBiotics Pharmaceuticals Inc.

On June 20, 2005, IntraBiotics Pharmaceuticals, Inc. announced that the Company was terminating all regular employees and ceasing all operations. It was also announced that the Company was appointing Hickey & Hill, Inc. to assume responsibilities for the day-to-day administration of the Company and that Mr. Hickey was to be designated Chief Executive Officer. Mr. Hickey has since been appointed Ch...

Greater Medical Center Group

The Greater Medical Center Group (GMCG) is a provider of U.S. Clerkships for International Medical Students and Graduates. As a network of professionals and educators, GMCG's mission is to standardize the clinical experience of medical students educated abroad while providing support services to international medical schools. Key executives are Dr. Stephen M. Cohen, Chief Executive Officer; ...

Relevant

Medivizor

Medivizor offers a patent-pending, personalized health information platform for individuals with serious or chronic illnesses. Users of Medivizor are benefiting from custom content, cutting-edge research, clear and authoritative descriptions of treatment options, individual-matched clinical trials, social engagement, and much more. Professor Steven ...

CreAgri, Inc.

Dr. Roberto Crea Moves to Chairman and Donald Ladwig Named CEO (Hayward, CA). CreAgri Inc., President and founder, Dr. Roberto Crea, announced that Donald Ladwig has assumed the duties as President and Chief Executive Officer of CreAgri Inc. and its subsidiary Supremo Extra Virgin Olive Oil. Dr. Crea will remain with the corporation as Chairman of the Board and Chief Scientist.

G & W Laboratories,Inc.

Carl Greenblatt founded G & W Laboratories, Inc. over eighty years ago upon his return from military service as a pharmacist with US forces in World War I. While establishing a reputation as an innovative specialist in suppository dosage forms, Carl guided G & W Laboratories with an uncompromising commitment to product integrity and customer service. In 1945, Carl's son, Burton, also a registered ...

THE MILES PARTNERSHIP

The Miles Partnership provides executive search services to UK and international clients across a range of sectors.The firm comprises five partners and is supported by an outstanding research team. The Miles partnership works at the highest levels of industry, recruiting chairmen, Chief Executive Partnership works at the highest levels of industry, recuiting Chairmen, Chief Executive Officers, Dir...

Baker Marquart LLP on behalf of Federico Pignatelli

Mr. Pignatelli served on the BIOLASE Board of Directors continuously from 1991 through August 2014 and is currently the beneficial owner of approximately 1.8 million shares of BIOLASE common stock. He served as Executive Chairman from 1994 through 2006. He was Chairman Emeritus from March 2006 to July 2010. He served as Chairman of the Board and as Chief E...

Sucampo Pharmaceuticals, Inc.

About chronic idiopathic constipation

China Health Holding

China Health Holding, Inc. (NASD OTCBB: CHHH) (“China Health” or “the Company”) is a development stage company, founded by the Company’s Chairman and Chief Executive Officer, Julianna Lu, in 2002 with the goal of becoming a leading developer, manufacturer, marketer and distributor in the global natural medical and pharmaceutical industry.

Dafra Pharma nv

Dafra Pharma started activities in December 1996. Dafra is a privately owned Belgian pharmaceutical company, established by Mr. Bruno Jansen (Chief Executive Officer). From the beginning, the company is dedicated towards identifying and developing antimalarial treatment products. Dafra has always been on the forefront of the artemisinin based therapies for treatment of malaria.

Palo Alto Investors, LLC

By: /s/ Will EdwardsName: Will Edwards, Chairman and Chief Investment Officer

iBionext

http://ibionext.com/


More From BioPortfolio on "Ibionext Chronolife Appoints Franck Meur Chief Executive Officer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks